GLAUCOMA داء الزرقاء.

Slides:



Advertisements
Similar presentations
Optic Disc Evaluation IN Glaucoma
Advertisements

PRIMARY ANGLE CLOSURE GLAUCOMA
Visual Field Examinations Week 5
Topical glaucoma medication with a teal cap? Prostaglandin analogues – Xalatan® (latanoprost) 0.005% qd – Travatan®(travoprost) 0.004% qd – Lumigan® (bimatoprost)
Paras Guide to Glaucoma
Glaucoma Clinical Update Barry Emara MD FRCS(C) Giovanni Caboto Club October 3, 2012.
Canadian Ophthalmological Society Evidence-based Clinical Practice Guidelines for the Management of Glaucoma in the Adult Eye.
Clinical Guidance and Monitoring for Change Cecilia Fenerty MD FRCOphth.
PRIMARY OPEN ANGLE GLAUCOMA(POAG)
Glaucoma Viviany Taqueti and Scott Vafai HST 150.
SAMIR AL-MANSOURI, MD. e.g. - cataract - glaucoma - macular degeneration - diabetic retinopathy Chronic = slowly progressive visual loss Major causes:
PRACTICAL APPROACH TO MEDICAL MANAGEMENT OF GLAUCOMA
Assessment and Management of Patients With Eye and Vision Disorders
بنام خداوند بخشنده مهربان
Glaucoma Glaucoma describes a number of ocular conditions characterized by: Raised intraocular pressure (IOP). Optic nerve head damage. Corresponding loss.
This talk relies on files accessible on line
Glaucoma Region XI “The Hot Splinters”. Definition A group of diseases caused by damage to the optic nerve that can gradually eliminate all sight A group.
The Canadian Association of Optometrists
Evaluation of the FDT perimeter for detection of glaucoma. eastMED Doctors
Barrow, Brantley, Fredde, Gillispie
Glaucoma Group of diseases characterized by increased intraocular pressure resulting in damage to the optic nerve and retinal nerve fibers.
INTRAOCULAR PRESSURE LECTURE
OPEN ANGLE GLAUCOMA Frank J. Weinstock, MD, FACS Professor of Ophthalmology- NEOUCOM Canton, Ohio USA.
Visual fields for General Practice
ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute of Ophthalmology ARAVIND EYE CARE SYSTEM Aravind Eye Hospital & Postgraduate Institute.
Ocular Ischaemic Syndrome Dr Gulrez Ansari Department of Ophthalmology Watford General Hospital 3 rd November 2004.
Will my Glaucoma patient lose vision ?
Is the Optic Disc Cupping or Sinking in Glaucoma?
RANDOMIZED CLINICAL TRIALS IN GLAUCOMA- WHAT DO THEY TELL US? Dr Jyoti Shetty B.W.Lions superspeciality eye hospital.
TARIQ ALASBALI WHICH PATIENTS ARE AT RISK FOR THE PROGRESSION?
Adult Medical-Surgical Nursing Neurology Module: Glaucoma.
Glaucoma Abdulrahman Al-Amri, MD. Glaucoma  Definition & Epidemiology  Anatomy & physiology  POAG  ACG  Secondary glaucoma  Management  Quiz.
Glaucoma.
Nursing care of patient with eye disorders
Dr. Abdullah Al-Amri Ophthalmology Consultant
Glaucoma Care Project Team Members: Geoffrey T. Emerick, M.D. Erin Herlihy, B.S. Marilyn Hauser, M.B.A. Dianna Greening, R.N. Walter M. Jay, M.D Opportunity.
Chronic Visual Loss. CHRONIC VISUAL LOSS 1. Measure intraocular pressure with a tonometer 2. Evaluate the nerve head 3. Evaluate the clarity of the lens.
GLAUCOMA.
Dr. T. Sarada M.S. Ophthalmology.  Congenital and developmental Glaucomas  Without associated anomalies - Primary congenital  With associated anomalies.
Dr. G. Rajasekhar MBBS, DNB, FRCS (Glasgow).  IOP  Angle  POAG  PACG  Acute congestive glaucoma  Drugs.
Glaucoma.
GLAUCOMA Dr. D.Chandrakanth. Chronic progressive Optic neuropathy by group of Ocular conditions( IOP ) Visual loss.
Dorzolamide A topical Carbonic anhydrase inhibitor. Ampholytic characteristics, hence good corneal penetration (depot effect achieved in cornea). Achieves.
PRIMARY OPEN ANGLE GLAUCOMA PROF.DR.ÖZCAN OCAKOĞLU.
Glaucoma Madhav Vempali Vempali Medical Ltd. Glaucoma The healthy eye Light rays enter the eye through the cornea, pupil and lens. These light rays are.
Glaucoma.
By Pharmacist Salwan Salem. * Is the organ which gives the sense of sight. * Eye allows us to see and interpret the shapes, colors, and dimensions of.
Glaucoma. Introduction  Glaucoma are ocular disorder characterized by changes in the optic nerve head (optic disc) and by loss of visual sensitivity.
Glaucoma Lily T. Im, MD. What is glaucoma?   Glaucoma is a group of diseases that damage the eye’s optic nerve and can result in vision loss and blindness.
A Deeper Look at Sight Threatening Conditions: Glaucoma, Macular Degeneration, and Diabetic Retinopathy Ashley S. Reddell, OD, FCOVD HOACLS 2015.
CONGENITAL GLAUCOMA PROF.DR.ÖZCAN OCAKOĞLU.
(Relates to Chapter 22, “Nursing Management: Visual and Auditory Problems,” in the textbook) Copyright © 2011, 2007 by Mosby, Inc., an affiliate of Elsevier.
Understanding Glauco ma. Femi Babalola Rachel eye center Garki, Abuja.
Phacomorphic Glaucoma
Safety of medication reduction for Primary Angle Closure (PAC) –
VISUAL ALTERATION GLAUCOMA.
Review of Glaucoma Suspect
SECONDARY GLAUCOMAS Dr. Shinisha Paul.
Pathogenesis of Glaucoma Translaminar-pressure difference
INTRODUCTION TO GLAUCOMA
PRIMARY OPEN-ANGLE GLAUCOMA
Clinical effect of citicoline combined with choline alfoscerate for treatment of glaucomatous optic neuropathy Karliychuk M.A., Pinchuk S.V. Department.
Determination of the Optic Disc Cupping in Glaucoma
Glaucoma Clinical features and management
David B Henson Medical School University of Manchester
Glaucoma.
Primary open angle glaucoma
Presentation transcript:

GLAUCOMA داء الزرقاء

LOOK OUT One of the leading causes of blindness Visual loss is irreversible Early diagnosis and proper management is important

Not A Single Disease A group of disorders characterized by: A progressive optic neuropathy resulting in a characteristic appearance of the optic disc, and a specific pattern of irreversible visual field defects, that are associated frequently but not invariably with raised IOP. {NTG ; OHT}

Classification Open Angle Glaucoma: A- Primary (POAG) B- Secondary (SOAG) Angle Closure Glaucoma: A- Primary (PACG) B- Secondary (SACG) 3. Congenital & Developmental Glaucoma: A- Primary Congenital Glaucoma B- Developmental Glaucoma (with associated anomalies)

Pathogenesis of Glaucomatous Ocular Damage Retinal ganglion cell death with loss of retinal nerve fibers due to: Raised IOP (mechanical theory) Pressure independent factors (vascular insufficiency theory)

Chronic glaucoma: what is happening Or poor blood supply here Either: the drain blocks here Damages the optic nerve..looks ‘caved in’, called ‘cupped’

POAG Chronic Simple Glaucoma Triad (Criteria of diagnosis) RISK FACTORS: Heredity. Age (5th-7th decade) Race (Black) Myopia. Retinal disease e.g. RP, CRVO DM Hypertension Central corneal thickness

PATHOGENESIS OF IOP RISE Impaired aqueous flow after the level of the angle e.g. Trabecular sclerosis.

CLINICAL FAETURES SYMPTOMS : ASYMPTOMATIC UNTILL TOO LATE PERIODIC CHECK UP after middle age. Mild headache, eye ache, frequent change of reading glasses, delayed dark adaptation.

SIGNS : Raised IOP: Normal value Diurnal variation NTG ,OHT Tonometry: {Digital, Indentation, Applanation, pneumatic tonometer,tonopen}

Normal central corneal thickness: 545 – 550 u Add or subtract 2.5 mmHg for each 50 u change in central corneal thickness

Glaucoma tonometry (pressure test)

Signs (Cont.) 2. Optic disc changes: Cupping ( normally up to 0.4) Large Asymmetry Progressive Vertical Notching Pallor Splinter hemorrhage Nerve fiber layer atrophy Marked cupping, nasal shift of blood vessels and CRA pulsation. Glaucomatous optic atrophy

Glaucoma damage

SIGNS (Cont.) 3. Specific Visual Field Changes:(Perimetry) Initially observed in Bjerrum area (10 – 30 degrees from the fixation point ) Small paracentral scotoma. Siedel scotoma (paracentral scotoma join the blind spot to form a sickle shaped scotoma) Arcuate scotoma (Siedel S. extend either above or below the fixation point) Ring (double arcuate) scotoma.

SIGNS (Cont.) 5. Roenne central nasal step. Roenne peripheral nasal step. Temporal wedge 8. Tubular vision 9. Temporal island of vision. PERIMETRY HUMPHRY VFA FREDQUENCY DOUBLING PERIMETER SHORT WAVE AUTOMATED PERIMETER (SWAP)

GOLDMANN PERIMETER

SIGNS (Cont.) 4-. Wide open angle on Gonioscopy. NB. Slit lamp examination to rule out causes of SOAG. Documentation of optic disc changes is very important. Recent tests e.g. Nerve fiber layer analyzer (NFLA) Optical coherence tomography (OCT)

MANAGEMENT EVALUATION & ASSESSMENT TARGET PRESSURE TEHRAPEUTIC CHOICE MEDICAL ALT or DLT FILTRATION SURGERY MONITORING & FOLLOW UP

MEDICAL THERAPY TERATMENT IS ESSENTIALLY MEDICAL TOPICAL DROPS (ORAL IS UNSUITABLE FOR LONG TERM TREATMENT) SINGLE OR COMBINATION Aim is to lower IOP Decrease aqueous production Increase aqueous drainage.

MEDICAL (Cont.) Topical beta blockers: decrease Aq. production Timolol maleate (0.25, 0.5% BD) Betaxolol (0.25% BD) in asthma. Levobunolol (0.25, 0.5% once daily) Carteolol (1% BD) low effect on lipoprotiens . SE & Contraindications? Pilocarpine (1- -4%, QDS): increase Aq. Outflow Ocular SE ? Systemic SE ? 3) Latanoprost (PG F2alpha analogue 0.005%, once daily) Increase uveoscleral aq. Outflow Expensive

MEDICAL (Cont.) 4) Dorzolamide (2% TDS ,carbonic anhydrase inhibitor), decrease Aq. Production 5) Adrenergic drugs: Epinephrine hydrochloride & Dipivefrine hydrochloride , increase outflow. Brimonidine (0.2%, BD), decrease Aq. production.

ALT Laser shots at the ant. part of TM will lead to stretching of adjacent area of TM Indication Failure of maximal tolerated medical therapy. Non compliance to medical therapy

Filtration surgery TARBECULECTOMY To create a fistula between AC & subconjunctival space thus provide a new channel for Aq. outflow Indication: Failure of medical & ALT Non compliance Non availability